体重指数<45与≥45子宫内膜癌患者前哨淋巴结定位成功率比较
回顾性图表审查纳入933例子宫内膜上皮内瘤变或临床1期子宫内膜癌患者,比较体重指数(BMI)<45与≥45组机器人辅助全腹腔镜子宫切除联合前哨淋巴结(SLN)定位的成功率。BMI≥45组双侧定位成功率45.7%低于BMI<45组的68.1%,定位失败率30.4%高于11.6%(p<.001)。
要点
- BMI≥45组双侧SLN定位成功率45.7%,低于BMI<45组的68.1%。
- BMI≥45组定位失败率30.4%,高于BMI<45组的11.6%(p<.001)。
- BMI 30至44组调整比值比0.36(95%CI 0.21-0.60),BMI≥45组0.10(95%CI 0.06-0.19),均以BMI<30为参照。
核心结论
- BMI≥45患者SLN定位成功率显著低于BMI<45患者。
- 了解病态肥胖患者SLN定位成功率对术前咨询、手术规划和制定风险相适应的术后治疗方案至关重要。
研究设计与样本
- 回顾性图表审查,纳入年龄≥18岁、子宫内膜上皮内瘤变或临床1期子宫内膜癌、2015年1月至2021年12月接受机器人辅助全腹腔镜子宫切除并尝试SLN定位的患者。
- 共纳入933例,BMI<45组795例(85.2%),BMI≥45组138例(14.8%)。
- 设置:三个城市转诊机构,1个学术型和2个社区型。
主要发现
- BMI<45组 vs BMI≥45组双侧定位成功分别为541例(68.1%) vs 63例(45.7%)。
- BMI<45组 vs BMI≥45组单侧定位成功分别为162例(20.4%) vs 33例(23.9%)。
- BMI<45组 vs BMI≥45组定位失败分别为92例(11.6%) vs 42例(30.4%)(p<.001)。
- 探索性分析提示双侧SLN定位成功率与BMI呈反向关系,BMI<20患者双侧SLN定位率为86.5%,BMI≥61患者为20.0%。
- 双侧SLN定位率下降最陡的区间为BMI 46至50组 vs 51至55组,分别为55.4% vs 37.5%。
关键数值与推荐
- 双侧SLN定位成功:BMI<45组541例(68.1%) vs BMI≥45组63例(45.7%)。
- 单侧SLN定位成功:BMI<45组162例(20.4%) vs BMI≥45组33例(23.9%)。
- 定位失败:BMI<45组92例(11.6%) vs BMI≥45组42例(30.4%)(p<.001)。
- 调整比值比(以BMI<30为参照):BMI 30至44组0.36(95%CI 0.21-0.60),BMI≥45组0.10(95%CI 0.06-0.19)。
临床怎么用
- 原文结论指出,了解病态肥胖患者SLN定位成功率对术前咨询、手术规划和制定风险相适应的术后治疗方案至关重要。
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: The objective is to evaluate the rate of sentinel lymph node (SLN) mapping in patients with body mass index (BMI [kg/m2]) BMI ≥ 45 compared with < 45. DESIGN: A retrospective chart review. SETTING: Three urban referral-based settings-1 academic and 2 community based. PATIENTS: Patients age ≥ 18 years, with endometrial intraepithelial neoplasia or clinical stage 1 endometrial cancer who underwent robot-assisted total laparoscopic hysterectomy with attempted SLN mapping between January 2015 and December 2021. INTERVENTIONS: Robot-assisted total laparoscopic hysterectomy with attempted SLN mapping. MEASUREMENTS AND MAIN RESULTS: A total of 933 subjects were included: 795 (85.2%) with BMI < 45 and 138 (14.8%) with BMI ≥ 45. Comparing the BMI < 45 with BMI ≥ 45 group, bilateral mapping was successful in 541 (68.1%) vs 63 (45.7%), respectively. Unilateral mapping was successful in 162 (20.4%) vs 33 (23.9%), respectively. Failure to map occurred in 92 (11.6%) vs 42 (30.4%) (p <.001), respectively. Exploratory analysis also suggested an inverse relationship between success rate of bilateral SLN mapping and BMI, with patients with BMI < 20 having bilateral SLN mapping rates of 86.5% and patients with BMI ≥ 61 having rates of 20.0%. The steepest decline in bilateral SLN mapping rates was from BMI group 46 to 50 compared to 51 to 55, at 55.4% to 37.5%, respectively. Adjusted odds ratio (compared with those with BMI < 30) for those in the BMI 30 to 44 group was 0.36 (95% confidence interval 0.21-0.60) and for those in the BMI ≥ 45 group was 0.10 (95% confidence interval 0.06-0.19). CONCLUSION: There is a statistically significant lower rate of SLN mapping in patients with a BMI ≥ 45 than BMI < 45. Understanding the success of SLN mapping in patients with morbid obesity is essential for preoperative counseling, surgical planning, and developing a risk-appropriate postoperative treatment plan.
引用
- Fennimore NJ, Fitch K, Kiff J, et al. Success Rates of Sentinel Lymph Node Mapping for Endometrial Cancer in Patients with Body Mass Index < 45 Compared with Body Mass Index ≥ 45. J Minim Invasive Gynecol. 2023. PMID: 37142090. doi:10.1016/j.jmig.2023.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。